| # | Drug | Count |
|---|---|---|
| 0 | INTERFERON BETA-1A | 412 |
| 1 | TREPROSTINIL | 348 |
| 2 | ETANERCEPT | 188 |
| 3 | BUPRENORPHINE | 168 |
| 4 | INTERFERON BETA-1B | 148 |
| 5 | TADALAFIL | 146 |
| 6 | AMBRISENTAN | 131 |
| 7 | GLATIRAMER ACETATE | 115 |
| 8 | ADALIMUMAB | 114 |
| 9 | NALTREXONE | 110 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXMEDETOMIDINE HCL | 1 | 0.0833 |
| 1 | ALCOHOL SWABS | 1 | 0.0263 |
| 2 | FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE | 1 | 0.0204 |
| 3 | AZELASTINE HYDROCHLORIDE, FLUTICASONE PROPIONATE | 2 | 0.0171 |
| 4 | LENACAPAVIR SODIUM | 7 | 0.0138 |
| 5 | AGING CHEST AND NECK RESCUE TREATMENT CREAM | 1 | 0.0112 |
| 6 | AFLIBERCEPT-AYYH | 1 | 0.0099 |
| 7 | INTERFERON BETA-1B | 148 | 0.0078 |
| 8 | APOMORPHINE HYDROCHLORIDE | 13 | 0.0077 |
| 9 | METHYLPREDNISOLONE ACETATE | 45 | 0.0055 |
| # | Drug class | Count |
|---|---|---|
| 0 | Interferon beta [EPC] | 413 |
| 1 | Prostacycline Vasodilator [EPC] | 350 |
| 2 | Endothelin Receptor Antagonist [EPC] | 226 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 210 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 201 |
| 5 | Partial Opioid Agonist [EPC] | 168 |
| 6 | Phosphodiesterase 5 Inhibitor [EPC] | 166 |
| 7 | Corticosteroid [EPC] | 141 |
| 8 | Insulin Analog [EPC] | 139 |
| 9 | GLP-1 Receptor Agonist [EPC] | 115 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sclerosing Agent [EPC] | 2 | 0.0044 |
| 1 | CD4-directed Blocking Antibody [EPC] | 2 | 0.0037 |
| 2 | Prostacycline [EPC] | 3 | 0.0032 |
| 3 | Carboxypeptidase [EPC] | 1 | 0.0028 |
| 4 | Prostacycline Vasodilator [EPC] | 350 | 0.0025 |
| 5 | Interferon beta [EPC] | 413 | 0.0021 |
| 6 | Partial Opioid Agonist [EPC] | 168 | 0.0018 |
| 7 | Soluble Guanylate Cyclase Stimulator [EPC] | 45 | 0.0013 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 166 | 0.0012 |
| 9 | Endothelin Receptor Antagonist [EPC] | 226 | 0.0011 |